相关实验视频
Updated: Jan 14, 2026

10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
15.0K
对围产性病原体Streptococcus agalactiae具有抗菌活性,并扰乱与人类妊娠膜的细菌相互作用
Riya Chinni1, Kensley Horner2, Walter Avila2
1Medicine Health and Society, Vanderbilt University, Nashville, Tennessee 37232, United States.
ACS bio & med chem Au
|October 20, 2025
概括
对B组链球菌 (GBS) 具有抗菌活性,抑制其生长和粘附. 这表明可能是一种具有成本效益的方法来减少GBS周产期感染.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 营养科学 营养科学
背景情况:
- 乙组链球菌 (GBS) 是一种致病性细菌,会导致严重的周围感染.
- 流行病学数据表明,可以防止感染,并支持健康的怀孕.
- 对抗GBS的潜在抗菌作用仍然未被探索.
研究的目的:
- 为了研究对GBS的抗菌活性.
- 评估对GBS生长和粘附于妊娠组织的影响.
- 为了比较殖民和入侵GBS菌株对的敏感性.
主要方法:
- GBS菌株 (殖民和侵入性) 暴露于不同度的.
- 评估细菌生长抑制对的反应.
- 在暴露后对孕期组织的GBS粘附度的评估.
主要成果:
- 显著抑制了GBS生长.
- 减少了GBS对妊娠组织的粘附.
- 殖民GBS菌株对的抑制作用比侵入性菌株更敏感.
结论:
- 对GBS具有抗微生物特性.
- 可以抑制GBS的生长,并减少它对母体组织的粘附.
- 是一种潜在的成本效益干预措施,用于预防与GBS相关的围产期感染.
相关概念视频
Surface Membrane Barriers
2.6K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.6K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K

